Cargando…
Peripheral‐blood cytopenia, an early indicator of inborn errors of immunity
Inborn errors of immunity (IEI) are inherited monogenic disorders resulting in defective immune response. Non‐infectious presentations are increasingly more apparent. Widely available, cost‐effective early indicators are needed. Peripheral‐blood cytopenia may be a presenting laboratory feature or an...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544345/ https://www.ncbi.nlm.nih.gov/pubmed/35791731 http://dx.doi.org/10.1111/bjh.18337 |
_version_ | 1784804576782712832 |
---|---|
author | Cornelissen, Helena M. Musekwa, Ernest M. Glashoff, Richard H. Esser, Monika Zunza, Moleen Abraham, Deepthi R. Chapanduka, Zivanai C. |
author_facet | Cornelissen, Helena M. Musekwa, Ernest M. Glashoff, Richard H. Esser, Monika Zunza, Moleen Abraham, Deepthi R. Chapanduka, Zivanai C. |
author_sort | Cornelissen, Helena M. |
collection | PubMed |
description | Inborn errors of immunity (IEI) are inherited monogenic disorders resulting in defective immune response. Non‐infectious presentations are increasingly more apparent. Widely available, cost‐effective early indicators are needed. Peripheral‐blood cytopenia may be a presenting laboratory feature or an observed secondary phenomenon. This retrospective review of the South African Primary Immunodeficiency Registry (SAPIDR) aimed to assess the haematological indices at presentation and their association with the International Union of Immunological Societies (IUIS) 2019 IEI classification and mortality. Of 396 patients on the SAPIDR, 66% (n = 257) had available haematological results. Sixty percent were males and 85% under 18 years. A majority (53%) had predominantly antibody deficiency. At presentation, infection was prominent (86%) followed by cytopenia (62%). Neutropenia was associated with IUIS III [odds ratio (OR) 3.65, confidence interval (CI) 1.44–9.25], thrombocytopenia with IUIS II (OR 14.39, CI 2.89–71.57), lymphopenia with IUIS I (OR 12.16, CI 2.75–53.73) and pancytopenia with IUSI I (OR 12.24, CI 3.82–39.05) and IUIS II (OR 5.99, CI 2.80–12.76). Cytopenia showed shorter overall survival (OR 2.81, CI 1.288–4.16). Cytopenias that are severe, persistent, unusual and/or recurrent should prompt further investigation for IEI. The full blood count and leucocyte differential may facilitate earlier identification and serve as an adjunct to definitive molecular classification. |
format | Online Article Text |
id | pubmed-9544345 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95443452022-10-14 Peripheral‐blood cytopenia, an early indicator of inborn errors of immunity Cornelissen, Helena M. Musekwa, Ernest M. Glashoff, Richard H. Esser, Monika Zunza, Moleen Abraham, Deepthi R. Chapanduka, Zivanai C. Br J Haematol Paediatrics Inborn errors of immunity (IEI) are inherited monogenic disorders resulting in defective immune response. Non‐infectious presentations are increasingly more apparent. Widely available, cost‐effective early indicators are needed. Peripheral‐blood cytopenia may be a presenting laboratory feature or an observed secondary phenomenon. This retrospective review of the South African Primary Immunodeficiency Registry (SAPIDR) aimed to assess the haematological indices at presentation and their association with the International Union of Immunological Societies (IUIS) 2019 IEI classification and mortality. Of 396 patients on the SAPIDR, 66% (n = 257) had available haematological results. Sixty percent were males and 85% under 18 years. A majority (53%) had predominantly antibody deficiency. At presentation, infection was prominent (86%) followed by cytopenia (62%). Neutropenia was associated with IUIS III [odds ratio (OR) 3.65, confidence interval (CI) 1.44–9.25], thrombocytopenia with IUIS II (OR 14.39, CI 2.89–71.57), lymphopenia with IUIS I (OR 12.16, CI 2.75–53.73) and pancytopenia with IUSI I (OR 12.24, CI 3.82–39.05) and IUIS II (OR 5.99, CI 2.80–12.76). Cytopenia showed shorter overall survival (OR 2.81, CI 1.288–4.16). Cytopenias that are severe, persistent, unusual and/or recurrent should prompt further investigation for IEI. The full blood count and leucocyte differential may facilitate earlier identification and serve as an adjunct to definitive molecular classification. John Wiley and Sons Inc. 2022-07-06 2022-09 /pmc/articles/PMC9544345/ /pubmed/35791731 http://dx.doi.org/10.1111/bjh.18337 Text en © 2022 The Authors. British Journal of Haematology published by British Society for Haematology and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Paediatrics Cornelissen, Helena M. Musekwa, Ernest M. Glashoff, Richard H. Esser, Monika Zunza, Moleen Abraham, Deepthi R. Chapanduka, Zivanai C. Peripheral‐blood cytopenia, an early indicator of inborn errors of immunity |
title | Peripheral‐blood cytopenia, an early indicator of inborn errors of immunity |
title_full | Peripheral‐blood cytopenia, an early indicator of inborn errors of immunity |
title_fullStr | Peripheral‐blood cytopenia, an early indicator of inborn errors of immunity |
title_full_unstemmed | Peripheral‐blood cytopenia, an early indicator of inborn errors of immunity |
title_short | Peripheral‐blood cytopenia, an early indicator of inborn errors of immunity |
title_sort | peripheral‐blood cytopenia, an early indicator of inborn errors of immunity |
topic | Paediatrics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544345/ https://www.ncbi.nlm.nih.gov/pubmed/35791731 http://dx.doi.org/10.1111/bjh.18337 |
work_keys_str_mv | AT cornelissenhelenam peripheralbloodcytopeniaanearlyindicatorofinbornerrorsofimmunity AT musekwaernestm peripheralbloodcytopeniaanearlyindicatorofinbornerrorsofimmunity AT glashoffrichardh peripheralbloodcytopeniaanearlyindicatorofinbornerrorsofimmunity AT essermonika peripheralbloodcytopeniaanearlyindicatorofinbornerrorsofimmunity AT zunzamoleen peripheralbloodcytopeniaanearlyindicatorofinbornerrorsofimmunity AT abrahamdeepthir peripheralbloodcytopeniaanearlyindicatorofinbornerrorsofimmunity AT chapandukazivanaic peripheralbloodcytopeniaanearlyindicatorofinbornerrorsofimmunity |